Viral Load Levels Among Newly Reported Acute HIV Infections in Shenzhen, 2018–2025 (Preprint)
UNSTRUCTURED Background: Early detection and diagnosis of early and acute HIV infection have remained core goals of HIV diagnosis and treatment in recent years, as they are vital to lowering transmission risk and improving patient prognosis. HIV viral load and CD4+ T-lymphocyte counts serve as key laboratory markers to assess disease progression and clinical staging among people living with HIV. Objective: We aimed to analyze the epidemiological profiles and characteristics of newly reported acute HIV cases in Shenzhen (2018–2025), using data on viral load, CD4+ T-lymphocyte counts and HIV recent-infection avidity assays. Methods: We collected HIV-1 nucleic acid testing (viral load detection) and CD4+ T-lymphocyte count data from samples with negative or indeterminate HIV antibody confirmatory results between April 2018 and December 2025. We analyzed the distribution of viral load levels and performed correlation analyses using SPSS. Result: A total of 6588 samples were tested by HIV‑1 nucleic acid assay. Of these, 729 (11.07%) were initially nucleic acid‑positive, with viral loads ranging from 1.43 to 8.84 log10 copies/mL and a mean value of 7.41 log10 copies/mL. CD4+ T‑lymphocyte counts ranged from 0.26 to 1768 cells/μL, with a median of 255 cells/μL. There was a significant negative correlation between HIV‑1 viral load and CD4+ T‑lymphocyte counts (r = -0.291, P < 0.01). Combined with HIV‑1 avidity testing results, some individuals were identified as having acute‑phase infection and were therefore excluded from late HIV presentation cases. Conclusion: Among newly reported HIV-infected individuals in Shenzhen, those with acute infection generally had higher viral load levels and lower CD4⁺ T‑lymphocyte counts. Most patients with low CD4⁺ T‑lymphocyte counts would be misclassified as late presenters if classified solely by CD4⁺ T‑lymphocyte thresholds (< 350 cells/μL or < 200 cells/μL) set by domestic and international expert consensus. Additional testing strategies are required to differentiate late HIV presentation from acute infection. These efforts can improve the accuracy of prevention and control measures, facilitate stratified interventions and targeted treatment for patients across various infection stages, and enable reliable estimation of the regional prevalence of late HIV presentation.
Authors
- Lan Wei (ORCID: https://orcid.org/0000-0002-7566-5176)
- Yongxia Gan (ORCID: https://orcid.org/0000-0002-5400-7449)
- Jin Zhao (ORCID: https://orcid.org/0000-0002-3266-0594)
- Yifan Cai
- Xiaohui Wang
- Yan Zhang
- Chenli Zheng
- Guilian Li
- Yifan Zhong (ORCID: https://orcid.org/0009-0005-6399-5396)
- Zhihao Lin
- Hao Li
Publication Details
- Published
- 2026-11-19
- DOI
- https://doi.org/10.2196/preprints.117302
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- preprint